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1. Introduction
Glue ear (otitis media with effusion, OME) is the commonest
cause of deafness in children in the developed world with point
prevalence in the region of 20%, and up to 80% of children are
affected at least temporarily by the age of 10 years [1,2]. OME,
acute otitis media (AOM) and recurrent AOM (3 or more episodes
in 6 months) are closely related clinical conditions [3]. AOM
represents an acute infective (bacterial and/or viral) process,
whereas OME is characterised by the presence of a middle ear
effusion in the absence of symptoms and signs of acute
inﬂammation [4]. OME and AOM are the leading cause of primary
care visits, and the most frequent reason for antibiotics or surgery
[5,6].
Although in themajority of cases OME is transient, a proportion
of children develop persistent symptoms that may affect hearing,
education, language or behaviour [2]. If OME persists after a three
month period of watchful waiting, treatment with ventilation
tubes (VTs or grommets) or hearing aids may be considered [2].
Most UK parents opt for surgery, and VT insertion is one of the
commonest surgical procedures in children in the developedworld
[4].
VT insertion is currently the only effective treatment to restore
hearing but it requires a general anaesthetic in children. In
addition, about a quarter of cases will require further surgical
treatment within 2 years [7], with the average number of
procedures per patient being 2.1 [8]. Numerous medical treat-
ments have also been tried. Antibiotics particularly have received
considerable attention, but although oral antibiotics are effective
in resolving OME in the short term, there is no long-term beneﬁt,
and it is not a recommended treatment in the UK [2,6,9].
Due to its major socio-economic and health care importance,
much attention has focused on the aetiology of OME [6]. It is a
chronic inﬂammatory condition affecting the middle ear mucosa
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Objective: Otitis media with effusion (OME), a common chronic childhood condition affecting hearing, is
thought to be a result of bacterial infection, with bioﬁlms recently implicated. Although bacterial DNA
can be detected by polymerase chain reaction in 80% of patients, typically fewer than half of effusions are
positive using standard culture techniques. We adopted an alternative approach to demonstrating
bacteria in OME, using a bacterial viability stain and confocal laser scanningmicroscopy (CLSM): staining
allows detection of live bacteria without requiring growth on culture, while CLSM allows demonstration
of the three-dimensional structure typical of bioﬁlms.
Methods: Effusion samples were collected at the time of ventilation tube insertion, analysed with CLSM
and bacterial viability stain, and extended culture techniques performed with the intention of capturing
all possible organisms.
Results: Sixty-two effusions (42 patients) were analysed: 28 (45.2%) were culture-positive, but 51
(82.3%) were CLSM-positive. Combining the two techniques demonstrated live bacteria in 57 (91.8%)
samples. Using CLSM, bacteria exhibited bioﬁlm morphology in 25 effusions and were planktonic in 26;
the proportion of samples exhibiting bioﬁlmmorphologywas similar in the culture-positive and culture-
negative groups (50.0% and 48.3%, respectively). Bioﬁlm samples contained an average of 1.7 different
bacterial isolates and planktonic samples 2.0, with the commonest bacteria identiﬁed being coagulase-
negative staphylococci.
Conclusion: Live bacteria are present inmost effusions, strongly suggesting that bacteria and bioﬁlms are
important in the aetiopathogenesis of OME.
 2012 Elsevier Ireland Ltd. All rights reserved.
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resulting in secretion of mucus that accumulates in the middle ear
cleft [4,10]. However, the cause of the inﬂammatory response has
been difﬁcult to identify especially because OME is not char-
acterised by symptoms and signs of acute inﬂammation thatwould
be expected in a typical acute bacterial infection caused by
planktonic bacteria; there is no pain, fever, or tympanic membrane
inﬂammation. The role of bacteria in OME has therefore been
controversial. The typical bacteria implicated in OME are
Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus
inﬂuenzae [4], but in most studies bacteria were culturable in less
than half of samples, ranging from21 to 70% [11–16]. Although this
may suggest that bacteria are not important in OME, it contrasts
with studies examining effusions for the presence of bacterial
nucleic acids by polymerase chain reaction (PCR), which have
demonstrated bacterial DNA typically in excess of 80% of effusions
[4,17,18]. However, the presence of bacterial nucleic acids does not
necessarily equate to the presence of viable bacteria as compo-
nents of effusion samples have been shown to inhibit nuclease
activity, and this has been postulated to cause the persistence of
RNA and DNA even if bacteria are no longer viable [19].
A possible explanation for the discrepancy between high PCR-
positive rate and low culture-positive rate in OME is the
involvement of bioﬁlms in the progression of this pathology
[20]. Indeed, bioﬁlms have been identiﬁed on human middle ear
mucosa in children with OME and/or recurrent AOM in more than
90% of cases, but not in any control samples studied [12]. In
addition to tissue surfaces, bioﬁlms have also been identiﬁed
attached tomucus [21,22] and attach in vitro to collagen gelmatrix
[23]. In OME, bioﬁlmsmay be attached tomucus aswell asmucosa,
thus providing the inﬂammatory stimulus leading to a middle ear
effusion [10,13,24].
To demonstrate bacteria and bioﬁlms in OME, an alternative
approach was adopted in this study. In addition to extended
microbial culture on a wide variety of media of middle ear effusion
samples taken at the time of VT insertion, effusions were also
analysed using a bacterial viability stain and confocal laser
scanning microscopy (CLSM). The advantage of the former
technique is that staining allows detection of live bacteria without
requiring them to grow on culture, while CLSM demonstrates
three-dimensional structure of bacterial communities typical of
bioﬁlms [25]. The results presented here differ fromdata presented
by Hall-Stoodley et al. in that the present analysis relates to the
middle ear effusion itself, rather than the mucosal biopsies
examined by previous research [12].
This study aimed to determine the proportion of effusion
samples that could be shown to contain live bacteria on extended
culture and/or CLSM with bacterial viability staining. We also
identiﬁed the bacteria involved, and determined whether they
existed as bioﬁlms in middle ear effusions.
2. Methods
The study was approved by Nottingham Research Ethics
Committee. Written informed consent was provided by the
parents or legal guardians of the study participants. Patients were
listed for VT insertion according to standard clinical practice:
symptomatic OME persisting for at least 3 months. The deliber-
ately wide inclusion criteria were chosen to maximise the
applicability of study results to clinical practice.
The ear canal was disinfected by instilling 70% isopropanol for
2 min, with swabs performed before and after alcohol disinfection.
Myringotomy was performed using standard aseptic technique,
and effusion aspirated into a sterile collection tube and transported
for immediate processing.
Samples were analysed in a dedicated microbiology laboratory
routinely involved in the processing of clinical samples for
research, supervised by a certiﬁed clinical microbiologist (RB).
Effusion sampleswere cultured on six differentmedia. Sheep blood
and MacConkey agar plates (Oxoid, Basingstoke, UK) were
incubated aerobically for up to threeweeks at 37 8C. The remaining
fourmedia (Helicobacter pylori, chocolatised blood forH. inﬂuenzae,
and Mycoplasma selective agars incubated in 5% CO2, and sheep
blood agar incubated anaerobically), were incubated for up to ten
weeks with rigorous precautions to prevent contamination.
Bacteria were identiﬁed using conventional tests including Gram
stain, catalase, oxidase and DNase production, optochin suscepti-
bility, response to growth factors X (haemin) and V (nicotinamide
adenine dinucleotide), and growth in anaerobic conditions, with
Analytical Proﬁle Index (API) strips (bioMe´rieux, Marcy l’Etoile,
France) used to speciate the isolates.
CLSM was performed using a Leica SP2 microscope, on
samples stained with LIVE/DEADTM stain (Molecular Probes, OR,
USA) according to the product literature protocol. The LIVE/
DEADTM stain employs differential membrane permeability to
stain intact and uncompromised bacterial cell membranes (i.e.
live bacteria) green with SYTO 9, whereas nuclei of dead bacteria
stain red with propidium iodide. Eukaryotic-derived material
also has a tendency to stain red. Morphology of bacterial
populations was also analysed. Bioﬁlms were identiﬁed on the
basis of well-established morphologic criteria that have been
applied to OME in the past [12,25]. Three-dimensional bacterial
clusters within an amorphous matrix and associated with a
surface such as eukaryotic cells or strands were classiﬁed as
bioﬁlms. In contrast, bacteria that appeared as individual
bacteria rather than a grouping were considered planktonic, as
were any bacterial groups that were not associated with a
surface. Typical examples are shown in Fig. 1. Two assessors (RB,
MD) determined bacterial morphology, and both were blinded to
the culture result.
Mucins were identiﬁed by Alcian blue/periodic acid Schiff (PAS)
staining. Samples were smeared thinly onto a glass slide and ﬁxed
in methanol. After addition of Alcian blue (HD Supplies, Aylesbury,
UK), slides were placed in 1% periodic acid, then Schiff’s reagent,
stained with Mayer’s haematoxylin, ‘‘blued’’ with 1% lithium
carbonate, and mounted in dibutyl phthalate in xylene (Sigma–
Aldrich, Poole, UK). Any mucin stains blue/purple in colour with
this technique.
PASW Statistics18 was used for statistical analysis.
3. Results
A total of 62 samples from 42 different patients (27 male, 15
female) were analysed. Most patients (35, 83.3%) were aged under
18 years, the median age being 4.5 years and age ranging from 1 to
75.
3.1. Canal disinfection
A random subset of 14 ears was analysed to assess effectiveness
of alcohol disinfection, by comparing culture results in swabs
taken before and after disinfection. Four swabs were culture
positive prior to disinfection (one containing Streptococcus
constelatus, one Bacillus spp., and two coagulase negative
staphylococci). All swab cultures were negative after disinfection.
3.2. Effusion culture and confocal microscopy
Twenty-eight of the 62 effusions were culture-positive (45.2%),
but CLSMdemonstrated live bacteria in 51 (82.3%) samples. Table 1
illustrates the relationship between culture and CLSM results,
showing that combining the two techniques identiﬁed live bacteria
in 57 effusions (91.9%).
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Among the CLSM-positive samples, 25 (49.0%) contained
bioﬁlms and 26 (51.0%) planktonic bacteria. Culture positivity
appeared not to inﬂuence bacterial morphology at CLSM, as the
proportion of samples exhibiting bioﬁlm morphology was similar
in the culture-positive and culture-negative groups (50.0% and
48.3%, respectively).
Differences between adults and children were explored on a
per-patient (rather than per-ear) basis; where data existed for two
ears, the per-patient analysis was carried out using the criteria of at
least one ear being culture/confocal positive and at least one ear
containing bioﬁlms. Children appeared to have a greater number of
culture-positive, confocal-positive, and bioﬁlm results than adults
(54.3% vs. 14.3%, 82.9% vs. 57.1%, and 67.9% vs. 0%, respectively).
However, only the presence of bioﬁlms reached statistical
signiﬁcance (Fisher’s exact test p = 0.02).
In the 20 patients (all children) in whom data from both ears
were available the correlation between the ﬁndings in the two ears
was assessed. The agreement rate was 70.0% (14/20) in the case of
culture positivity rate (kappa = 0.381, fair agreement), 90.0% (18/
20) in the case of confocal positivity rate (kappa = 0.444, moderate
agreement), and 58.8% (10/17 confocal positive samples) in the
case of confocalmorphology type (kappa = 0.168, poor agreement).
The same bacteria were identiﬁed in both ears in 7 children
(35.0%).
Table 2 shows the range of different bacterial isolates, including
the relationship of bacterial isolates to CLSM ﬁndings. The mean
number of different bacterial isolates was 1.8 per culture-positive
sample, with no signiﬁcant difference between confocal-positive
and confocal-negative samples. Bioﬁlm samples contained an
average of 1.7 and planktonic samples 2.0 different bacterial
isolates, but thiswas not statistically signiﬁcant on t-test (p = 0.51).
[(Fig._1)TD$FIG]
Fig. 1. CLSM images showing live bacteria staining green, whereas dead bacteria and eukaryotic cells/material stain red. (A) Bacterial clusters associated with what appear to
be erythrocytes, in a culture-negative sample. (B) Copious planktonic bacteria (arrow) in a culture-negative sample. (C and D) Bacterial bioﬁlms (arrow) associated with
strands, both shown on an x–y–z projection to give three-dimensional information, in a sample containing S. aureus,M. catarrhalis, F. oryzihabitans, and V. metschnikovii. (E and
F) Bacterial bioﬁlms represented on a grid to give three-dimensional information, in a culture-negative sample). (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of the article.)
Table 1
Comparison of culture and confocal microscopy results; percentages refer to the
percent out of all 62 samples.
CLSM-positive CLSM-negative Total
Culture-positive 22 (35.5%) 6 (9.7%) 28 (45.2%)
Culture-negative 29 (85.3%) 5 (8.1%) 34 (54.8%)
Total 51 (82.3%) 11 (17.7%) 62
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Fig. 1 shows representative images obtained by CLSM. The red
strands observed at CLSM had the appearance of mucin, conﬁrmed
with Alcian blue/PAS staining (Fig. 2).
4. Discussion
4.1. Summary of ﬁndings
The results show that combining culture and confocal
microscopy enables demonstration of live bacteria in more than
90% of OME samples, strongly suggesting a role for bacteria in the
aetiopathogenesis of OME. Extended cultures alone were positive
in 45.2%. However, CLSM was positive in 82.3%, and in these
samples bioﬁlms were demonstrated in 49.0%. A wide variety of
different bacteria were also identiﬁed, rather than just the
traditional three studied in the past (S. pneumoniae, H. inﬂuenzae,
M. catarrhalis).
4.2. Bioﬁlms in OME
The microbiology of OME has been studied for many decades,
yet controversy still exists as to the role of bacteria in the aetiology
of OME [4,26]. A high proportion of effusions (typically more than
half) are culture-negative [11–16]. However, while PCR has
demonstrated bacterial nucleic acids in a much greater number
of patients [4,17,18], nucleic acids identiﬁed at PCR may not
represent viable bacteria, even when the quantitative technique of
real time PCR is used [27], although a novel technique of
differentiating whether DNA comes from live or dead bacteria
has recently been developed [28]. An alternative view of bacteria in
OME is that they might be viable but not culturable by
conventional means, a state that is commonly seen in bioﬁlms
[29,30]. An additional problem is the issue of sampling: a bioﬁlm
may be localised to only one part of the effusion, so unless the
entire effusion is analysed, a localised bioﬁlm may be missed.
Our data add to current knowledge of bacterial and bioﬁlm
involvement in OME as we examined mucus as the site of bioﬁlm
attachment rather than mucosa, and clearly demonstrated that
the bacteria were viable (something that PCR cannot do) in more
than 90% of samples [4,12,20,31,32]. Bioﬁlms and bacterial
structural components may themselves be pathogenic, and have
been shown to cause inﬂammatory cytokine release [13,33], but
may also act as a reservoir of bacteria, with some bacteria leaving
the bioﬁlm to become planktonic and disseminated. While
bacteria in bioﬁlm mode are usually in dormant phase and do
not, for instance, produce toxins or invasion-related virulence
factors, this facility can be restored on reversion to planktonic
mode [34].
Using CLSMwewere able to detect bioﬁlms in just under half of
CLSM-positive samples. However, CLSM identiﬁed live bacteria in
85.3% of the culture-negative samples. Among culture-negative
samples 14.7% were also confocal-negative, but of the culture-
positive samples 21.4%were confocal-negative. This suggests that
CLSM may under-estimate the presence of bacteria, perhaps due
to sampling differences, especially important where small
samples of effusion were divided between several tests. There
appeared to be no great difference between planktonic and
bioﬁlmbacteria identiﬁedon LCSM-positive samples,with similar
numbers being culture-positive. Although one might have
expected all samples containing planktonic bacteria to have been
culture-positive according to the non-culturable bioﬁlm theory,
16 such effusions were culture-negative. It is possible that these
bacteria did exist in bioﬁlm form (which would make them
difﬁcult to culture), but that their original morphology was
Table 2
Different bacterial species isolated from effusion samples, and their relationship to confocal microscopy ﬁndings. Number (N) refers to the number of isolates rather than the
number of samples. The coagulase-negative staphylococci (CoNS) isolates were 2 S. lugdunensis, 2 S. epidermidis, one each S. simulans, S. capitis and S. hominis, and one sample
contained both S. capitis and S. lugdunensis. Acinetobacter consisted of one A. lwofﬁi and one A. radioresistens, and Pseudomonas consisted of one P. aeruginosa, one P. stutzeri and
one P. luteola isolates.
Bacteria Culture results Confocal microscopy
N (%) isolates among all 62 samples Negative Positive Bioﬁlm Planktonic
CoNS 8 (12.9) 1 7 2 5
Veillonella spp. 6 (9.7) 3 3 3
Staphylococcus aureus 5 (8.1) 5 1 4
Streptococcus pneumoniae 4 (6.5) 1 3 2 1
Bacillus spp. 3 (4.8) 1 2 1 1
Moraxella catarrhalis 3 (4.8) 1 2 1 1
Pseudomonas spp. 3 (4.8) 3 3
Acinetobacter spp. 2 (3.2) 2
Corynebact. propinquum 2 (3.2) 2 1 1
Flavimonas oryzihabitans 2 (3.2) 2 2
Haemophilus inﬂuenzae 2 (3.2) 2 2
Helicobacter pylori 2 (3.2) 2 1 1
Vibrio metschnikovii 2 (3.2) 2 2
Gemella haemolysans 1 (1.6) 1 1
Kocuria varians/rosea 1 (1.6) 1 1
Micrococcus sp. 1 (1.6) 1 1
Peptococcus sp. 1 (1.6) 1
[(Fig._2)TD$FIG]
Fig. 2. Alcian blue/periodic acid Schiff staining of effusion demonstrating mucin
strands stained blue/purple. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of the article.)
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disturbed by the process of surgical aspiration or laboratory
preparation/mixing. The fact that some effusions containing
bioﬁlms on confocal microscopy were culture positive is not
surprising as bacteria frombioﬁlms frequently leave the bioﬁlm to
enter the planktonic state (and would therefore be culturable),
and processing of samples for analysis may also disrupt the
bioﬁlm thus rendering the bacteria planktonic and the culture
positive. Children’s effusions appeared to be more likely to
contain bioﬁlms than adults, in keeping with the expected
infective aetiology of OME in children but a possibly different
aetiology in adults [4]. No great correlation between ﬁndings in
the opposite ears has been demonstrated, suggesting that
individual ears may be subject to different local aetiopathogenic
mechanisms.
Bioﬁlms were identiﬁed on the basis of well-established
morphological criteria that have been applied to OME in the
recent past, i.e. the presence of three-dimensional bacterial
clusters within an amorphous matrix and associated with a
surface such as eukaryotic cells or strands [12,25]. Although the
BacLight stain enables differentiation only between bacteria with
intact and damaged cytoplasmic membranes it is often used to
differentiate between active and dead cells [35,36], and while it
appears to be reasonable to consider membrane-compromised
bacterial cells as dead, the reverse (i.e. intact membrane signiﬁes
live cells) may not be true in a small number of cases [35].
However, given that 82.3% of the samples in this study stained live
on confocal microscopy, a small false-live rate will still leave the
majority of samples containing live bacteria.
The question of whether OME is a bioﬁlm infection has been
addressed by Fergie et al. [20]. Parsek and Singh suggested that the
following criteria should be fulﬁlled for a disease to be considered a
bioﬁlm infection [25]:
 Bacteria are adherent to substratum or a surface.
 Bacteria are living in cell clusters ormicro-colonies encased in an
extracellular matrix.
 Infection is generally conﬁned to a particular location.
 Infection is difﬁcult or impossible to eradicate with antibiotics,
despite the responsible bacteria being susceptible to the
antibiotic when in the planktonic state.
Our results show that extended culture techniques and
confocal microscopy together can identify live bacteria in 92% of
cases, and we found bioﬁlms in just under half of effusions.
Although studies of middle ear mucosa have shown bioﬁlms in
most (but not all) samples, this does not necessarily contradict
our ﬁndings as there are several reasons why this difference
between mucosa and mucus may exist [12,32]. It is possible that
bioﬁlms exist on the mucosa in most people with OME but exist
within the effusion associated with mucins in only just under
half of cases, or that bioﬁlms on mucosa act as reservoirs of
bacteria that then enter the effusion, or that there is an issue
with which part of the effusion is sampled for analysis. The
presence of an intact mucus layer appears to be important in
controlling bacteria within the human gastro-intestinal tract as
most bacteria reside on the luminal side of the mucus layer [37],
with no direct contact with the epithelium unless inﬂammation
is present [38,39].
Could bioﬁlms be a part of the normal middle ear ﬂora rather
than the pathogenic cause of OME? While Hall-Stoodley [12] did
not ﬁnd any bioﬁlms in their healthy controls, another study [40] of
middle ear mucosal biopsy at time of cochlear implant showed
bioﬁlms in 2 out of 45 cases without evidence of previous otologic
problems or abnormalities, suggesting that bioﬁlms may exist in
the asymptomatic middle ear. The difﬁculty when researching
bioﬁlms in OME is choice of control group. Entirely normal patients
do not require ear surgery, and all the control groups chosen are
patients having surgery for another (ostensibly non-related)
reason, but they cannot be considered to be normal. When
studying effusions as in this study, the problem is compounded by
the fact that the normal ear does not have an effusion, therefore no
suitable negative control exists. A further problem relates to the
common phenomenon of temporary OME, so it possible that
children considered ‘‘normal’’ may have bioﬁlms in their middle
ear because they have a temporary problem that would never
come tomedical attention otherwise. Nevertheless, the presence of
a bioﬁlm may lead to an inﬂammatory stimulus that results in
middle ear mucosal inﬂammation and therefore clinical OME
[10,13]. Bioﬁlms have also been found in patients with choles-
teatoma and chronic suppurative otitis media [32,41].
4.3. Bacterial types in OME
S. pneumoniae, M. catarrhalis and H. inﬂuenzae are the most
common pathogens implicated in OME, and all are capable of
forming bioﬁlms [33,42]. However, rather than focusing just on
those three bacteria, this study cultured effusions on a wide range
of differentmedia for prolonged time periods in order to capture as
many isolates as possible. Interestingly, coagulase negative
staphylococci (CoNS), Veillonella spp. and S. aureus were the three
commonest pathogens isolated in this study. CoNS were long
thought to be non-pathogenic commensals, but with the recogni-
tion of their bioﬁlm-forming capacity have emerged as the leading
cause of biomaterials-related infection [43,43]. S. lugdunensis,
isolated here on three occasions, in particular has been implicated
in endocarditis, wound infection, and implant-related infection as
well as otitis media, behaving more like S. aureus than other CoNS
[45]. Other CoNS have also been previously implicated in otitis
media, with a recent study ﬁnding that they account for 60% of
bacteria isolated from OME [46,47]. Veillonella is a Gram-negative
anaerobe that inhabits the mouth and upper respiratory tract,
forms bioﬁlms [48] and has previously been found in middle ear
disease [49,50]. S. aureus also forms bioﬁlms and has been
identiﬁed in middle ear disease [51,52]. Although most of the
bacteria in Table 2 have previously been isolated in middle ear
disease, to the best of the authors’ knowledge Flavimonas
oryzihabitans, Vibrio metschnikovii and Gemella haemolysans have
not been implicated previously.
It is unclear why the present study identiﬁed the three
traditional OME bacteria in a lower proportion of samples than
other studies. Although the samples in this study may have been
cultured for longer periods of time (with the intention of
identifying slow-growing species) than is typical in the routine
diagnostic laboratory, the authors do not consider that results
represent contamination as stringent precautions were taken.
Variation in prevalence of OME over time has been previously
documented [16], and may be due to patterns of antibiotic use or
vaccination, particularly with the introduction of vaccines against
H. inﬂuenzae type b and S. pneumoniae. The adoption of a broad
microbiological approach in this study with the aim of identiﬁca-
tion of all bacteria may also have detected species missed by
studies adopting a narrower culturing approach. Confocal micros-
copy itself does not allow identiﬁcation of bacterial species,
therefore Hall-Stoodley et al. have characterised bacteria by
ﬂuorescence in situ hybridisation [12]. However, as bacterial
identiﬁcation is obtained only when a species-speciﬁc probe is
used, this approach is not suitable when trying to identify every
species as part of a strategy aimed at identifying the broadest
possible range of bacterial species.
Although numbers of isolates of any one bacterial species are
small, it is interesting to note that majority of samples that grew
CoNS and S. aureus on culture appeared to contain planktonic
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bacteria on confocal microscopy, despite both being well-
recognised as bioﬁlm-forming pathogens [43,44,51]. Pseudomonas
aeruginosa, which is well known to produce bioﬁlms [42] was also
identiﬁed in bioﬁlm morphology in this study, but Acinetobacter
appeared difﬁcult to detect on CLSM.
4.4. Glue ear treatment
This study clearly implicates bacteria in the aetiopathogenesis
of OME. Our study ﬁnds bioﬁlms in 49.0% of confocal-positive
effusions, and previous research has demonstrated them on more
than 90% of mucosal biopsies in children with OME or recurrent
AOM [12]. This new understanding of OME aetiology also leads to
potentially novel therapeutic possibilities that may improve
current management options. At present, treatment of persistent
symptomatic OME involves drainage of the effusion and VT
insertion, but this does not address any persistent bacterial
infection, and serves to merely remove the effusion that is the
result of a middle ear inﬂammation. It is therefore perhaps not
surprising that about a quarter of caseswill require further surgical
treatment within 2 years, and the average number of procedures
per child is greater than two [7,8].
Unlike planktonic bacteria, which would be expected to
respond to conventional antibiotic treatment, bacteria in
bioﬁlms adopt a distinct phenotype with a slow growth rate
that makes them recalcitrant to standard antibacterial therapy
[42,53,54]. However, novel antibacterial strategies such as
locally delivered high-dose antibiotics over a prolonged time
period [53,54] or new drug delivery systems and antimicrobial-
impregnated devices appear promising [53,55,56], and other
novel techniques such as ultrasound [57,58], low-strength
electrical ﬁelds [59], enzymatic degradation of extracellular
matrix [60], inhibition of quorum sensing [61–63], disruption of
bioﬁlm-related genes, or indeed a combination of the above in a
smart system that detects and treats bioﬁlm infection [64] might
be of interest. However, at present the application of these
approaches to OME remains speculative.
5. Conclusion
The role of bacteria in OME has been controversial, with a long-
held debate fuelled by the low number of effusions that are
culture-positive and the controversy over whether PCR-positive
samples indicate live bacteria. However, this study, using extended
cultures and confocal microscopy, demonstrates live bacteria in
more than 90% of middle ear effusions in children with glue ear,
strongly suggesting that bacteria and bioﬁlms are important in the
pathogenesis of the condition.
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